Recovery Techniques for Functional Visual Symptoms

Refers to:

For a fuller description of this symptom and the diagnostic techniques used to assess it, see Understanding & Diagnosis.

assessed functional visual loss affecting clarity or visual fields, with separately assessed photophobia where relevant. The principal clinical review does not cover functional eye-movement disorders or visual snow; these approaches must not be generalized to double vision or every visual complaint. Migraine and eye or neurological disease can coexist. 1 Also described as: functional visual loss, functional visual disorder and, in older literature, non-organic visual loss.

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For the Person With FND

Vision can be disabling even when examination shows that some visual function is available. Ask what the positive findings mean, what they cannot establish, and how the team will address daily access and any coexisting conditions. A brief useful response does not establish reliable vision for driving, work or walking. 1

Choose a relevant detailed page

• Positive Explanation of Preserved Vision and Follow-Up — The person has an assessed functional visual-loss pattern and needs to understand the positive findings, remaining uncertainty and continuing-care plan. [Specialist clinical guidance; explanation is not a guaranteed vision-restoring treatment]
• Noticing Briefly Better Vision Without Repeated Testing — Occasional useful visual moments occur naturally and can help identify a workable task or setting without increasing checking. [Specialist clinical guidance; no isolated efficacy evidence]
• Orthoptist-Guided Visual Feedback — A specialist has identified a specific preserved visual response that can be explained and explored safely during an appointment. [Specialist clinical practice; direct treatment evidence is limited]
• Graded Visual Tasks Linked to Daily Life — An assessed, low-risk visual task is possible and can be adjusted toward a specific reading, locating or everyday goal. [Clinical rehabilitation adaptation; no established universal exercise dose]
• Supported Visual Choice Without Waiting for Certainty — A clinician-selected matching or pointing task may reveal usable information even when the person cannot confidently describe what they see. [Specialist clinical example; experimental therapeutic use rather than a validated home test]
• Photophobia: An Agreed Light and Protection Plan — Light sensitivity limits activities and specialist assessment supports considering a tolerable, individualized change alongside treatment of relevant causes. [Specialist clinical guidance; FND-specific exposure evidence is limited and there is no universal schedule]
• Treatment of Coexisting Eye, Migraine and Neurological Conditions — Functional visual symptoms coexist with a treatable eye, headache or neurological problem, or a changed presentation needs reassessment. [Clinical assessment and condition-specific care; improvement does not identify a single mechanism]
• Hypnotherapy and Transparent Therapeutic Suggestion — A person wishes to discuss an optional clinician-delivered approach after the diagnosis and uncertain evidence have been explained. [Emerging, very limited visual-specific evidence; not established routine treatment]
• Advanced Visual Feedback and Non-Invasive Brain Stimulation: Specialist Review — A specialist or research team is evaluating an experimental visual-feedback or stimulation approach after discussing uncertainty and alternatives. [Experimental or early clinical-report evidence; no established self-treatment protocol]

If symptoms flare, with or without warning

Stop visually hazardous activity. If you are already driving, stop as safely as possible and get assistance; do not resume until safe and consistent with medical and licensing advice. Ask for help reaching a stable place, and use your usual visual or mobility supports. Do not begin stairs, cooking or tools while vision is unreliable.

For a familiar episode, follow the agreed plan. One comfortable cue or task may help if previously selected with your clinician, but you do not have to practise during a flare. If there is no warning, plan access to help and environmental safety in advance. Resume an ordinary low-risk activity only when manageable, and review any prolonged or delayed worsening before increasing practice. These are practical care adaptations, not a tested universal flare protocol.

Retain needed light protection and accessible formats. A selected light-exposure trial is a shared treatment decision, not permission for anyone to remove glasses or make you endure worsening. Photophobia has multiple possible causes. 1 4

A changed symptom pattern needs a new decision

Seek emergency help for sudden inability to see from one or both eyes or sudden severe eye pain. New flashes, a dark shadow, double vision or a red painful eye need urgent medical advice. Do not drive yourself for urgent assessment. An existing functional diagnosis does not explain every later symptom. 3

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Family, Friends, and Other Supporters

Ask what kind of guidance or physical assistance the person wants. Keep routes predictable, offer accessible information and retain needed aids. Never surprise them with obstacles, wave objects to test vision, secretly record a response or use an examination finding to challenge their honesty.

During a familiar flare, help stop hazardous activity and follow the agreed plan. If symptoms are new or substantially changed, help obtain medical advice. Practice is optional and should stop when it becomes distressing or unsafe. Notice a useful adaptation neutrally; lack of improvement is not evidence of insufficient effort or belief.

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Clinicians and the Care Team

Establish positive functional findings within an appropriate ophthalmic or neuro-ophthalmic assessment. Document the visual phenomenon, uncertainty and coexisting disease. Explain the difference between an available response and dependable everyday function. Coordinate orthoptics, ophthalmology, neurology and rehabilitation according to need. 1

For an agreed trial:

1. Identify a meaningful daily goal and the person’s current access requirements.
2. Select one relevant approach, explaining the evidence limitations and alternatives.
3. Demonstrate a tolerable task in a stable setting, with consent and a clear stopping signal.
4. Specify assistance, light/contrast demand and the smallest manageable practice amount; avoid a universal dose.
5. Review participation, discomfort, fatigue and delayed effects before changing one demand.
6. Record the familiar-flare plan, urgent reassessment criteria and follow-up responsibility.

These steps are an educational clinical adaptation, not a validated protocol. Do not reproduce optical examination procedures, rapid visual stimulation or brain-stimulation methods as unsupervised exercises. Hypnosis and stimulation require qualified specialist review and explicit discussion of uncertainty. Continuing disability warrants support whether or not practice changes vision. 1 2

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

Research and Sources

The 2024 clinical review supports positive explanation, selected demonstrations and rehabilitation, and management of comorbidity. Its practical recommendations are not controlled evidence for each individual exercise. The 2026 systematic review includes 44 studies and 2,284 patients across epidemiology, prognosis and treatment, but finds very limited treatment data. These are not 44 treatment trials, and heterogeneous prognosis findings do not establish a personal recovery timetable. 1 2

The NHS source supplies adjacent urgent-assessment guidance, not FND treatment evidence. The photophobia review supports considering ophthalmic and neurological causes; it does not validate a functional-photophobia exposure schedule. 3 4

No new community quotations are included. Lived-experience review should cover helpful, neutral and adverse experiences, access needs and no-warning episodes without being presented as efficacy evidence.

Citation	Full citation
[1]	Ramsay N, McKee J, Al-Ani G, Stone J. How do I manage functional visual loss. Eye. 2024;38:2257–2266. FND-CIT-0024. Source
[2]	Ramsay N, Tessmann H, McKee J, Ercoli T, Stone J. Functional visual loss: a systematic review and meta-analysis of epidemiology, prognosis and treatment. Eye. 2026;40:1784–1793. Published online June 26, 2026. FND-CIT-0103. Source
[3]	NHS. Vision loss. Reviewed August 28, 2025; accessed September 16, 2026. FND-CIT-0104. Source
[4]	Digre KB, Brennan KC. Shedding light on photophobia. Journal of Neuro-Ophthalmology. 2012;32(1):68–81. FND-CIT-0105. Source

Evidence checked September 16, 2026 · Ophthalmology, orthoptics, lived-experience and accessibility review pending.

---

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —